NasdaqGM - Nasdaq Real Time Price USD

Merrimack Pharmaceuticals, Inc. (MACK)

14.73 +0.05 (+0.34%)
As of 9:53 AM EDT. Market Open.
Advanced Chart
Loading Chart for MACK
DELL
  • Previous Close 14.68
  • Open 14.68
  • Bid 14.65 x 200
  • Ask 14.74 x 100
  • Day's Range 14.68 - 14.73
  • 52 Week Range 11.53 - 15.89
  • Volume 12,711
  • Avg. Volume 128,145
  • Market Cap (intraday) 214.053M
  • Beta (5Y Monthly) 1.43
  • PE Ratio (TTM) --
  • EPS (TTM) -0.08
  • Earnings Date May 2, 2024 - May 6, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 13, 2019
  • 1y Target Est --

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

www.merrimack.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Merrimack Pharmaceuticals, Inc.

Recent News: MACK

View More
View More

Performance Overview: MACK

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MACK
9.84%
S&P 500
5.11%

1-Year Return

MACK
16.81%
S&P 500
20.66%

3-Year Return

MACK
109.83%
S&P 500
19.78%

5-Year Return

MACK
381.80%
S&P 500
72.58%

Compare To: MACK

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

MACK
Merrimack Pharmaceuticals, Inc.
14.73
+0.34%
Mkt Cap 214.053M
Industry Biotechnology
ESLA
Estrella Immunopharma, Inc.
1.0000
-1.96%
Mkt Cap 36.611M
Industry Biotechnology
INBX
Inhibrx, Inc.
34.54
+0.26%
Mkt Cap 1.637B
Industry Biotechnology
RPHM
Reneo Pharmaceuticals, Inc.
1.7109
-2.79%
Mkt Cap 57.18M
Industry Biotechnology
ADAG
Adagene Inc.
2.6300
+1.94%
Mkt Cap 116.133M
Industry Biotechnology
OBIO
Orchestra BioMed Holdings, Inc.
4.6600
-1.06%
Mkt Cap 166.723M
Industry Biotechnology
MLEC
Moolec Science SA
1.3101
-5.07%
Mkt Cap 56.081M
Industry Biotechnology
TIL
Instil Bio, Inc.
10.36
+0.53%
Mkt Cap 67.348M
Industry Biotechnology
AVTE
Aerovate Therapeutics, Inc.
21.91
+1.44%
Mkt Cap 610.478M
Industry Biotechnology
LRMR
Larimar Therapeutics, Inc.
6.37
-0.16%
Mkt Cap 406.406M
Industry Biotechnology
PHAR
Pharming Group N.V.
9.33
-2.96%
Mkt Cap 686.985M
Industry Biotechnology

Statistics: MACK

View More

Valuation Measures

As of 4/18/2024

  • Market Cap

    213.33M

  • Enterprise Value

    194.45M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    11.38

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -89.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -6.97%

  • Return on Equity (ttm)

    -6.22%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.18M

  • Diluted EPS (ttm)

    -0.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.88M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.13M

View More

Research Analysis: MACK

View More

Fair Value

Overvalued
% Return
14.73 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 
View More

People Also Watch

FOLD Amicus Therapeutics, Inc.
10.54
+2.03%
 
CLDX Celldex Therapeutics, Inc.
38.41
-0.31%
 
AGIO Agios Pharmaceuticals, Inc.
30.18
+2.55%
 
PTCT PTC Therapeutics, Inc.
25.05
+1.46%
 
PBYI Puma Biotechnology, Inc.
5.05
+1.20%
 
OMER Omeros Corporation
3.2275
+0.55%
 
RGLS Regulus Therapeutics Inc.
2.3093
+4.02%
 
HALO Halozyme Therapeutics, Inc.
38.48
+1.77%
 
MGNX MacroGenics, Inc.
16.29
+1.37%
 
CMRX Chimerix, Inc.
0.9201
-1.31%
 
ENTA Enanta Pharmaceuticals, Inc.
13.44
+1.59%
 
OCUL Ocular Therapeutix, Inc.
5.57
-5.03%
 
LXRX Lexicon Pharmaceuticals, Inc.
1.6650
+2.15%
 
IRWD Ironwood Pharmaceuticals, Inc.
7.82
+2.83%
 
VSTM Verastem, Inc.
10.36
+1.22%
 
KPTI Karyopharm Therapeutics Inc.
1.3000
+1.56%